Skip to main content
Top
Published in: Esophagus 2/2016

01-04-2016 | Original Article

Usefulness of two-point fixed endoscopic submucosal dissection for superficial esophageal neoplasms

Authors: Osamu Motohashi, Ken Nishimura, Norisuke Nakayama, Yasuhiro Inokuchi, Syuntaro Inoue

Published in: Esophagus | Issue 2/2016

Login to get access

Abstract

Background

Endoscopic submucosal dissection (ESD) is becoming widely regarded as a highly complicated but useful treatment for superficial esophageal neoplasms. However, the technique tends to be associated with adverse events. To evaluate the safety and utility of two-point fixed ESD for superficial esophageal neoplasms, and to discuss future directions.

Methods

Between December 2006 and December 2013, we performed two types of ESD procedures, the two-point fixed ESD that uses continuous countertraction to ensure a sufficient operative field was performed in 107 patients and conventional ESD was performed in 80 patients. Short-term outcomes and adverse events were evaluated. This study was retrospective study from a single institution.

Results

Significant differences were observed between conventional ESD and the two-point fixed ESD with regard to the operation time, tumor positive and unknown vertical margins of the resected specimen, perforation as an adverse event, mediastinal emphysema, and postoperative stenosis.

Conclusion

The two-point fixed ESD is a very useful method compared with the conventional procedure.
Literature
1.
go back to reference Motohashi O, Takagi S, Yonemitsu K, et al. Test production and utility of an ESD assistive device (transparent hood with mucosa gripping channel attached) (for animal studies and clinical use). Gastroenterol Endosc. 2006;48:2518–25 (Japanese with English abstract). Motohashi O, Takagi S, Yonemitsu K, et al. Test production and utility of an ESD assistive device (transparent hood with mucosa gripping channel attached) (for animal studies and clinical use). Gastroenterol Endosc. 2006;48:2518–25 (Japanese with English abstract).
2.
go back to reference Motohashi O, Nishimura K, Nakayama N, et al. Endoscopic submucosal dissection (two-point fixed ESD) for early esophageal cancer. Dig Endosc. 2009;21:176–9.CrossRefPubMed Motohashi O, Nishimura K, Nakayama N, et al. Endoscopic submucosal dissection (two-point fixed ESD) for early esophageal cancer. Dig Endosc. 2009;21:176–9.CrossRefPubMed
3.
go back to reference Motohashi O. Two-point fixed endoscopic submucosal dissection in rectal tumor (with video). Gastrointest Endosc. 2011;74:1132–6.CrossRefPubMed Motohashi O. Two-point fixed endoscopic submucosal dissection in rectal tumor (with video). Gastrointest Endosc. 2011;74:1132–6.CrossRefPubMed
4.
go back to reference Higuchi K, Tanabe S, Azuma M, et al. A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG0901). Gastrointest Endosc. 2013;78:704–10.CrossRefPubMed Higuchi K, Tanabe S, Azuma M, et al. A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG0901). Gastrointest Endosc. 2013;78:704–10.CrossRefPubMed
5.
go back to reference Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–94.CrossRefPubMed Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–94.CrossRefPubMed
6.
go back to reference Motohashi O, Takagi S, Nakayama N, et al. Utility of an ESD procedure of esophagus using assistive device (transparent hood with mucosa gripping channel attached) (An examination of animal studies). Gastroenterol Endosc. 2007;49:2819–24 (Japanese with English abstract). Motohashi O, Takagi S, Nakayama N, et al. Utility of an ESD procedure of esophagus using assistive device (transparent hood with mucosa gripping channel attached) (An examination of animal studies). Gastroenterol Endosc. 2007;49:2819–24 (Japanese with English abstract).
7.
go back to reference Imaeda H, Iwao Y, Ogata H, et al. A new technique for endoscopic submucosal dissection for early gastric cancer using an external grasping forceps. Endoscopy. 2006;38:1007–10.CrossRefPubMed Imaeda H, Iwao Y, Ogata H, et al. A new technique for endoscopic submucosal dissection for early gastric cancer using an external grasping forceps. Endoscopy. 2006;38:1007–10.CrossRefPubMed
8.
go back to reference Gotoda T, Oda I, Tamakawa K, et al. Prospective clinical trial of magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer (with videos). Gastrointest Endosc. 2009;69:10–5.CrossRefPubMed Gotoda T, Oda I, Tamakawa K, et al. Prospective clinical trial of magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer (with videos). Gastrointest Endosc. 2009;69:10–5.CrossRefPubMed
9.
go back to reference Morita Y, Masuda M, Tanaka S, et al. A new approach to treating difficult cases of early gastric cancer: development of a double scope-ESD using transnasal endoscope with a “Split Barrel”. Endoscopia Digestiva. 2010;22:846–51 (Japanese with English abstract). Morita Y, Masuda M, Tanaka S, et al. A new approach to treating difficult cases of early gastric cancer: development of a double scope-ESD using transnasal endoscope with a “Split Barrel”. Endoscopia Digestiva. 2010;22:846–51 (Japanese with English abstract).
Metadata
Title
Usefulness of two-point fixed endoscopic submucosal dissection for superficial esophageal neoplasms
Authors
Osamu Motohashi
Ken Nishimura
Norisuke Nakayama
Yasuhiro Inokuchi
Syuntaro Inoue
Publication date
01-04-2016
Publisher
Springer Japan
Published in
Esophagus / Issue 2/2016
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-015-0513-5

Other articles of this Issue 2/2016

Esophagus 2/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine